Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angelman Syndrome | 18 | 2022 | 136 | 6.290 |
Why?
|
Seizures | 16 | 2023 | 2859 | 2.040 |
Why?
|
Anticonvulsants | 13 | 2023 | 1916 | 1.550 |
Why?
|
Epilepsies, Myoclonic | 3 | 2018 | 80 | 1.280 |
Why?
|
Trisomy | 3 | 2015 | 266 | 1.000 |
Why?
|
Chromosomes, Human, Pair 15 | 8 | 2020 | 373 | 0.880 |
Why?
|
Glycemic Index | 2 | 2017 | 395 | 0.840 |
Why?
|
Spasms, Infantile | 2 | 2023 | 305 | 0.810 |
Why?
|
Electroencephalography | 15 | 2022 | 6150 | 0.780 |
Why?
|
GABA Agonists | 1 | 2020 | 111 | 0.740 |
Why?
|
Isoxazoles | 1 | 2020 | 216 | 0.680 |
Why?
|
Epilepsy | 12 | 2019 | 3310 | 0.680 |
Why?
|
Gastrointestinal Diseases | 2 | 2017 | 1170 | 0.610 |
Why?
|
Diazepam | 1 | 2018 | 205 | 0.600 |
Why?
|
Phenylalanine-tRNA Ligase | 1 | 2016 | 16 | 0.570 |
Why?
|
Meningoencephalitis | 1 | 2014 | 78 | 0.480 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 895 | 0.440 |
Why?
|
Status Epilepticus | 1 | 2018 | 444 | 0.430 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.410 |
Why?
|
Encephalitis | 1 | 2014 | 423 | 0.380 |
Why?
|
Child, Preschool | 22 | 2021 | 41006 | 0.380 |
Why?
|
Autoantibodies | 1 | 2018 | 2035 | 0.360 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 996 | 0.350 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2012 | 262 | 0.340 |
Why?
|
Heterozygote | 1 | 2016 | 2804 | 0.340 |
Why?
|
Hernia | 1 | 2008 | 71 | 0.330 |
Why?
|
Delta Rhythm | 2 | 2021 | 78 | 0.320 |
Why?
|
Frontal Lobe | 1 | 2014 | 1406 | 0.310 |
Why?
|
Anxiety | 3 | 2021 | 4297 | 0.310 |
Why?
|
Ambulatory Care | 1 | 2018 | 2708 | 0.290 |
Why?
|
Child | 25 | 2023 | 77709 | 0.290 |
Why?
|
Adolescent | 23 | 2021 | 85781 | 0.290 |
Why?
|
Syndrome | 3 | 2022 | 3251 | 0.260 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2008 | 475 | 0.260 |
Why?
|
Infant | 13 | 2023 | 35136 | 0.260 |
Why?
|
Data Collection | 1 | 2014 | 3341 | 0.240 |
Why?
|
Massachusetts | 4 | 2018 | 8663 | 0.240 |
Why?
|
Constipation | 2 | 2018 | 546 | 0.200 |
Why?
|
Treatment Outcome | 9 | 2023 | 63114 | 0.190 |
Why?
|
Male | 33 | 2021 | 350118 | 0.190 |
Why?
|
Young Adult | 12 | 2021 | 56430 | 0.190 |
Why?
|
Ambulatory Care Facilities | 2 | 2018 | 933 | 0.190 |
Why?
|
Mutation | 7 | 2019 | 29786 | 0.190 |
Why?
|
Sleep | 1 | 2016 | 4623 | 0.180 |
Why?
|
Brain | 6 | 2019 | 26385 | 0.180 |
Why?
|
Fumarate Hydratase | 1 | 2019 | 47 | 0.180 |
Why?
|
Brain Diseases | 1 | 2008 | 1563 | 0.170 |
Why?
|
Female | 32 | 2021 | 380194 | 0.170 |
Why?
|
Chromosome Duplication | 2 | 2019 | 74 | 0.170 |
Why?
|
Humans | 44 | 2023 | 744343 | 0.170 |
Why?
|
Hyperventilation | 1 | 2019 | 81 | 0.170 |
Why?
|
Psychomotor Disorders | 1 | 2019 | 152 | 0.170 |
Why?
|
Buspirone | 1 | 2019 | 82 | 0.160 |
Why?
|
Piracetam | 2 | 2009 | 87 | 0.160 |
Why?
|
Retrospective Studies | 13 | 2018 | 77449 | 0.160 |
Why?
|
Muscle Hypotonia | 1 | 2019 | 165 | 0.160 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4933 | 0.150 |
Why?
|
Double-Blind Method | 2 | 2023 | 12026 | 0.150 |
Why?
|
Chromosome Aberrations | 4 | 2019 | 1813 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 35421 | 0.150 |
Why?
|
Metabolism, Inborn Errors | 1 | 2019 | 288 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 5 | 2021 | 1861 | 0.150 |
Why?
|
Adult | 16 | 2023 | 214055 | 0.150 |
Why?
|
Facies | 2 | 2019 | 197 | 0.150 |
Why?
|
Phenotype | 6 | 2022 | 16365 | 0.140 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 440 | 0.140 |
Why?
|
Electrodiagnosis | 1 | 2016 | 151 | 0.140 |
Why?
|
Senna Extract | 1 | 2015 | 3 | 0.130 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2015 | 24 | 0.130 |
Why?
|
Vomiting | 1 | 2018 | 636 | 0.130 |
Why?
|
Bisacodyl | 1 | 2015 | 12 | 0.130 |
Why?
|
Uniparental Disomy | 1 | 2014 | 43 | 0.130 |
Why?
|
Dysarthria | 1 | 2014 | 57 | 0.120 |
Why?
|
Enema | 1 | 2015 | 141 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2016 | 3760 | 0.120 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.120 |
Why?
|
Tuberous Sclerosis | 2 | 2013 | 1029 | 0.120 |
Why?
|
Puerto Rico | 1 | 2014 | 356 | 0.120 |
Why?
|
Autistic Disorder | 2 | 2013 | 1185 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12959 | 0.110 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1941 | 0.110 |
Why?
|
Chromosome Disorders | 1 | 2016 | 514 | 0.110 |
Why?
|
Disease Management | 3 | 2019 | 2459 | 0.110 |
Why?
|
Chromosomes | 1 | 2016 | 596 | 0.110 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 135 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6489 | 0.110 |
Why?
|
Biopolymers | 1 | 2013 | 189 | 0.110 |
Why?
|
Malformations of Cortical Development | 1 | 2014 | 200 | 0.100 |
Why?
|
Age Distribution | 1 | 2018 | 2902 | 0.100 |
Why?
|
Ataxia | 1 | 2014 | 304 | 0.100 |
Why?
|
Scoliosis | 1 | 2018 | 725 | 0.100 |
Why?
|
Valproic Acid | 2 | 2016 | 445 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2016 | 1850 | 0.100 |
Why?
|
Gastroesophageal Reflux | 1 | 2018 | 782 | 0.100 |
Why?
|
Prevalence | 2 | 2018 | 15226 | 0.090 |
Why?
|
Cohort Studies | 6 | 2019 | 40561 | 0.090 |
Why?
|
Social Adjustment | 1 | 2012 | 631 | 0.090 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2014 | 372 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8324 | 0.090 |
Why?
|
Microcephaly | 1 | 2014 | 432 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4037 | 0.090 |
Why?
|
Canada | 1 | 2014 | 2065 | 0.090 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1182 | 0.080 |
Why?
|
Clonazepam | 1 | 2009 | 136 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1580 | 0.080 |
Why?
|
Parent-Child Relations | 1 | 2012 | 747 | 0.080 |
Why?
|
Intelligence | 1 | 2012 | 920 | 0.080 |
Why?
|
Triazines | 1 | 2009 | 315 | 0.070 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 807 | 0.070 |
Why?
|
Epilepsy, Generalized | 1 | 2009 | 174 | 0.070 |
Why?
|
Bhutan | 2 | 2017 | 60 | 0.070 |
Why?
|
Drug Tolerance | 1 | 2008 | 376 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1637 | 0.070 |
Why?
|
Vagus Nerve Stimulation | 1 | 2009 | 199 | 0.070 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1681 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2014 | 2418 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.060 |
Why?
|
Drug Resistance | 1 | 2009 | 1609 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2008 | 1285 | 0.060 |
Why?
|
Prognosis | 3 | 2017 | 29063 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3675 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5708 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4776 | 0.040 |
Why?
|
Middle Aged | 5 | 2020 | 213383 | 0.040 |
Why?
|
Quality of Life | 2 | 2018 | 12804 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7729 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1A | 1 | 2019 | 53 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2020 | 328 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2019 | 25625 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 564 | 0.040 |
Why?
|
Comorbidity | 2 | 2009 | 10388 | 0.040 |
Why?
|
Blood Glucose | 1 | 2012 | 6256 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39050 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6038 | 0.040 |
Why?
|
Pediatrics | 1 | 2012 | 3475 | 0.040 |
Why?
|
Phenytoin | 1 | 2016 | 197 | 0.030 |
Why?
|
Carbamazepine | 1 | 2016 | 229 | 0.030 |
Why?
|
Serotonin | 1 | 2019 | 1017 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 775 | 0.030 |
Why?
|
Genotype | 2 | 2020 | 12951 | 0.030 |
Why?
|
Cognition Disorders | 2 | 2018 | 4043 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 53288 | 0.030 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 329 | 0.030 |
Why?
|
Body Fat Distribution | 1 | 2013 | 244 | 0.030 |
Why?
|
Pedigree | 1 | 2019 | 4644 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 2013 | 190 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 292 | 0.020 |
Why?
|
Movement Disorders | 1 | 2015 | 445 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2015 | 675 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2094 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 2013 | 374 | 0.020 |
Why?
|
Epilepsy, Absence | 1 | 2009 | 48 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2014 | 1401 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 184 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3407 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2690 | 0.020 |
Why?
|
United States | 1 | 2014 | 69872 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1420 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
Epilepsies, Partial | 1 | 2009 | 436 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15540 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2849 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4186 | 0.010 |
Why?
|
Animals | 1 | 2013 | 168757 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2009 | 1004 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4467 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.010 |
Why?
|
Risk Factors | 1 | 2013 | 72290 | 0.000 |
Why?
|
Aged | 1 | 2016 | 163280 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_